Tectonic Therapeutic | AVRO - Spese Di Vendita E Di Amministrazione





Spese Di Vendita E Di Amministrazione Cambiamento Data
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alnylam Pharmaceuticals USD 282.51M 2.55M 2026-03
Celltrion KRW 12.71B 237.27B 2025-12
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 6.57M 1.62M 2025-12
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Gilead Sciences USD 1.45B 326M 2026-03
Ionis Pharmaceuticals USD 151M 21M 2026-03
Kangmei Pharma CNY 237.06M 37.35M 2026-03
Karyopharm Therapeutics USD 9.56M 17.63M 2025-12
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
MacroGenics USD 7.94M 1.96M 2025-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
Organigram Holdings CAD 7.73M 1.13M 2025-12
Ovoca Bio EUR 632K 2.33M 2025-06
Pfizer USD 2.92B 1.16B 2026-03
Pharma Mar EUR 15.31M 2M 2026-03
Qiagen NV USD 153.88M 10.77M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sanofi EUR 2.33B 419M 2026-03
Sarepta Therapeutics USD 54.03M 51.35M 2026-03
Sartorius EUR 221.3M 500K 2026-03
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Takeda JPY 292B 9.21B 2026-03
Tilray USD 24.85M 1.7M 2025-09
Zealand Pharma A/S 91.81M 99.04M 2025-12
Zz Pientze Pharmaceu CNY 214.31M 42.4M 2026-03